Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions01:27

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

401
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
401
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action01:17

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

1.7K
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
1.7K
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics01:11

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics

437
All neuromuscular blocking agents are injected intravenously because they are poorly absorbed from the GI tract. Rapid onset is achieved with intravenous administration, although absorption is also adequate from an intramuscular injection. Since these agents are highly ionized, they do not readily penetrate cell membranes or cross the blood-brain barrier.
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
437
Neuromuscular Junction And Blockade01:29

Neuromuscular Junction And Blockade

3.0K
The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
3.0K
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

348
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
348
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

477
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
477

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Excelsatoxin A-Receptor TMEM233 Modulates Nav1.8.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same author

Determinants for Activation of the Ion Channel TRPV3 by Weak Acids.

International journal of molecular sciences·2025
Same author

Weak Acids as Endogenous Inhibitors of the Proton-Activated Chloride Channel.

Cells·2025
Same author

The Minimal Spherical Dispersion.

Journal of geometric analysis·2024
Same author

The coumarin osthole is a non-electrophilic agonist of TRPA1.

Neuroscience letters·2022
Same author

The impact of modified fluid gelatin 4% in a balanced electrolyte solution on plasma osmolality in children-A noninterventional observational study.

Paediatric anaesthesia·2022
Same journal

[Infection Prevention in the Intensive Care Unit: Evidence-Based Strategies for Reducing Healthcare-Associated Infections].

Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS·2026
Same journal

[Persistent Postoperative Opioid Use].

Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS·2026
Same journal

[Dexamethasone for Perioperative Analgesia].

Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS·2026
Same journal

[Treatment Expectations in the Perioperative Setting - Influence on Postoperative Pain Treatment].

Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS·2026
Same journal

Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS·2026
Same journal

[Correction: Anaesthesiological Concepts in Paediatric Neurosurgery].

Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS·2026
See all related articles

Related Experiment Video

Updated: Jun 15, 2025

Author Spotlight: Translational Applications of Stimulated SFEMG in Rodent Models
04:30

Author Spotlight: Translational Applications of Stimulated SFEMG in Rodent Models

Published on: March 8, 2024

649

[Neuromuscular Blockade in Geriatric Patients].

Daniel Rudolf

    Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS
    |August 28, 2024
    PubMed
    Summary
    This summary is machine-generated.

    Neuromuscular blocking agents are vital in anesthesia, but geriatric patients need specific administration protocols. This article details these adapted approaches for elderly individuals.

    More Related Videos

    The Neuromuscular Junction: Measuring Synapse Size, Fragmentation and Changes in Synaptic Protein Density Using Confocal Fluorescence Microscopy
    12:18

    The Neuromuscular Junction: Measuring Synapse Size, Fragmentation and Changes in Synaptic Protein Density Using Confocal Fluorescence Microscopy

    Published on: December 26, 2014

    21.7K
    Deep Neuromuscular Blockade Leads to a Larger Intraabdominal Volume During Laparoscopy
    08:50

    Deep Neuromuscular Blockade Leads to a Larger Intraabdominal Volume During Laparoscopy

    Published on: June 25, 2013

    13.2K

    Related Experiment Videos

    Last Updated: Jun 15, 2025

    Author Spotlight: Translational Applications of Stimulated SFEMG in Rodent Models
    04:30

    Author Spotlight: Translational Applications of Stimulated SFEMG in Rodent Models

    Published on: March 8, 2024

    649
    The Neuromuscular Junction: Measuring Synapse Size, Fragmentation and Changes in Synaptic Protein Density Using Confocal Fluorescence Microscopy
    12:18

    The Neuromuscular Junction: Measuring Synapse Size, Fragmentation and Changes in Synaptic Protein Density Using Confocal Fluorescence Microscopy

    Published on: December 26, 2014

    21.7K
    Deep Neuromuscular Blockade Leads to a Larger Intraabdominal Volume During Laparoscopy
    08:50

    Deep Neuromuscular Blockade Leads to a Larger Intraabdominal Volume During Laparoscopy

    Published on: June 25, 2013

    13.2K

    Area of Science:

    • Anesthesiology
    • Pharmacology

    Context:

    • Neuromuscular blocking agents (NMBAs) are integral to modern anesthesia.
    • Anesthesia management requires tailored approaches for specific patient groups.

    Purpose:

    • To discuss the specialized administration of NMBAs in geriatric patients.
    • To highlight adaptations needed for elderly individuals undergoing anesthesia.

    Summary:

    • This article reviews the use of neuromuscular blocking agents in anesthesia.
    • It focuses on the unique considerations and adapted administration strategies for geriatric patients.

    Impact:

    • Provides essential guidance for anesthesiologists managing elderly patients.
    • Aims to optimize NMBA use and patient safety in geriatric anesthesia care.